Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Argenteuil
Clinical trial register · France

Clinical Trials in Argenteuil, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Angers4 Intergroupe Francophone du Myelome4 French Innovative Leukemia Organisation4 Assistance Publique - Hôpitaux de Paris3 The Lymphoma Academic Research Organisation3
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Argenteuil

75 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Central Hospital, Nancy, France
Not applicable
800
Argenteuil, Clermont-Ferrand, Épagny, Lille, Mulhouse, Nancy, Paris, Poitiers
2027-01-10
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 1/2
44
Amiens, Angers, Annecy, Argenteuil, Bayonne, Bordeaux, Brest, Caen
2026-12-01
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
95
Lyon, Argenteuil, Avignon, Bayonne, Bordeaux, Cergy-Pontoise, Corbeil-Essonnes, Estaing
2026-12
Not yet open
University Hospital, Clermont-Ferrand
Phase 3
1,600
Aix-en-Provence, Amiens, Argenteuil, Arras, Bordeaux, Brest, Caen, Clermont-Ferrand
2026-11
Not yet open
Wockhardt
Phase 3
324
Lille, Paris, Argenteuil
2026-10-28
Not yet open
Diaphragm Response in Elderly for Acute Monitoring
NCT07132268Acute Dyspnea, Acute Respiratory Failure, Diaphragmatic Ultrasound
Centre Hospitalier de Bethune
Observational
145
Argenteuil, Béthune, Douai, Le Puy-en-Velay, Melun, Roubaix, Saint-Lô, Tourcoing
2026-10
Not yet open
Philippe ROUSSELOT
Phase 2
93
Aix-en-Provence, Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Bobigny
2026-09-01
Not yet open
University Hospital, Angers
Observational
5,760
Angers, Argenteuil, Brest, Chartres, Cholet, Clermont-Ferrand, Grenoble, Laval
2026-09-01
Not yet open
Early Corticosteroids in Severe Influenza Pneumonia
NCT07786662Severe Influenza, Intensive Care (ICU), Reanimation, Infectious Diseases
Centre Hospitalier Régional Metz-Thionville
Phase 3
544
Argenteuil, Bobigny, Bourg-en-Bresse, Caen, Cannes, Cherbourg, Colombes, Créteil
2026-09
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
350
Argenteuil, Aulnay-sous-Bois, Bondy, Bordeaux, Boulogne-Billancourt, Bry-sur-Marne, Cergy-Pontoise, Clamart
2026-07-15
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Argenteuil, Bayonne, Le Mans, Nantes
2026-06-30
Not yet open
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
NCT07665788Ventilator-Associated Pneumonia, Ventilator-Associated Tracheobronchitis
University Hospital, Tours
Phase 3
250
Angers, Argenteuil, Blois, Bourg-en-Bresse, Créteil, Dieppe, Dijon, Dreux
2026-06-01
Not yet open
University Hospital, Angers
Not applicable
568
Angers, Argenteuil, Brest, Cholet, Clermont-Ferrand, Colombes, Grenoble, Le Mans
2026-06
Not yet open
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Observational
50
Argenteuil, Bordeaux, Garches, Levallois-Perret, Nantes, Nice, Paris, Tourcoing
2026-03-15
Recruiting
Elion Therapeutics, Inc.
Phase 2
60
Argenteuil, Créteil, Paris
2026-02-13
Recruiting
UNICANCER
Phase 3
3,902
Amiens, Angers, Argenteuil, Aurillac, Auxerre, Avignon, Bayonne, Beauvais
2025-12-18
Recruiting
mylife Diabetes Care AG
Observational
125
Amiens, Angers, Argenteuil, Bois-Guillaume, Bordeaux, Brest, Bron, Grenoble
2025-12-11
Recruiting
French Innovative Leukemia Organisation
Phase 2
33
Amiens, Angers, Argenteuil, Avignon, Besançon, Clamart, Clermont-Ferrand, Corbeil-Essonnes
2025-12-11
Recruiting
Glofitamab in Real Life
NCT06994169Large B-cell Lymphoma
DrugGlofitamab
The Lymphoma Academic Research Organisation
Observational
250
Argenteuil, Avignon, Bayonne, Besançon, Clamart, Créteil, Dijon, Dunkirk
2025-12-01
Not yet open
French Innovative Leukemia Organisation
Phase 2
102
Amiens, Angers, Annecy, Argenteuil, Bayonne, Besançon, Bordeaux, Caen
2025-12-01
Recruiting
University Hospital, Tours
Not applicable
1,078
Amiens, Angers, Argenteuil, Belfort, Besançon, Béthune, Blois, Bordeaux
2025-11-30
Recruiting
Incyte Corporation
Phase 3
250
Argenteuil, Bordeaux, Créteil, Lyon, Nantes, Nice, Paris, Reims
2025-11-13
Recruiting
Nantes University Hospital
Not applicable
686
Angers, Angoulème, Argenteuil, Nantes, Arles, Avignon, Belfort, Bordeaux
2025-11-11
Recruiting
Versailles Hospital
Phase 3
674
Amiens, Angers, Annecy, Argenteuil, Aurillac, Brest, Brive-la-Gaillarde, Caen
2025-11-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,084
Amiens, Angers, Argenteuil, Bobigny, Bourg-en-Bresse, Colombes, Corbeil-Essonnes, Créteil
2025-08-19
Recruiting
University Hospital, Limoges
Phase 3
326
Angers, Argenteuil, Belfort, Brive-la-Gaillarde, Chalon-sur-Saône, Dijon, Garches, Le Chesnay
2025-07-09
Recruiting
Intergroupe Francophone du Myelome
Phase 3
824
Amiens, Angers, Annecy, Argenteuil, Avignon, Bayonne, Besançon, Blois
2025-07-09
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
420
Nice, Bordeaux, Nantes, Rouen, Sainte-Maxime, Argenteuil, Brest, Cenon
2025-04-29
Recruiting
Thermes de Bareges
Not applicable
70
Argenteuil, Pierrefitte-Nestalas
2025-04-28
Recruiting
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial
Centre Hospitalier Régional d'Orléans
Observational
600
Amiens, Argenteuil, Bayonne, Besançon, Béthune, Bobigny, Bourgoin, Chambéry
2025-03-11
Recruiting
Bristol-Myers Squibb
Observational
350
Amiens, Angers, Argenteuil, Arras, Bordeaux, Chalon-sur-Saône, Clermont-Ferrand, Dijon
2025-01-29
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Argenteuil, Caen, Le Mans, Mulhouse, Nice, Tours
2025-01-03
Recruiting
Nantes University Hospital
Not applicable
830
Albi, Amiens, Angers, Angoulême, Argenteuil, Belfort, Besançon, Béthune
2024-12-14
Recruiting
Basilea Pharmaceutica
Phase 3
450
Amiens, Argenteuil, Marseille, Nantes, Rennes, Tours
2024-12-11
Recruiting
University Hospital, Rouen
Phase 4
133
Amiens, Angers, Argenteuil, Bobigny, Bordeaux, Brest, Caen, Clermont-Ferrand
2024-12-04
Not yet open
Postoperative Extubation in Hypoxemic Patients
NCT06688487Hypoxemia, Extubation, Postoperative Respiratory Complication
Fondation Hôpital Saint-Joseph
Not applicable
152
Argenteuil, Besançon, Le Plessis-Robinson, Montpellier, Paris, Reims, Saint-Denis
2024-11-18
Active, closed
AbbVie
Phase 3
699
Toulouse, Vandœuvre-lès-Nancy, Bordeaux, Nantes, Clermont-Ferrand, Amiens, Paris, Argenteuil
2024-08-19
Active, closed
Pfizer
Observational
450
Bordeaux, Argenteuil, Caen, Dijon, La Tronche, Lille, Rennes, Rouen
2024-08-07
Recruiting
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
NCT06195540Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Lower Limb Trauma
DrugRivaroxaban
University Hospital, Angers
Phase 3
1,424
Agen, Angers, Argenteuil, Arpajon, Caen, Chambray-lès-Tours, Cholet, Clermont-Ferrand
2024-07-19
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
310
Agen, Aix-en-Provence, Amiens, Antony, Argenteuil, Arras, Aurillac, Auxerre
2024-02-26
Active, closed
Sanofi
Observational
303
Amiens, Angers, Argenteuil, Armentières, Arras, Ars-Laquenexy, Avignon, Besançon
2023-11-28
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 4
600
Argenteuil, Avignon, Bordeaux, Boulogne-Billancourt, Clermont-Ferrand, Clichy, Étampes, La Roche-sur-Yon
2023-11-13
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Antony, Argenteuil
2023-10-12
Active, closed
PRostate Olaparib Real World Evidence Study
NCT06031805Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Observational
159
Amiens, Angers, Antony, Argenteuil, Avignon, Besançon, Bordeaux, Challes-les-Eaux
2023-10-11
Active, closed
Intergroupe Francophone du Myelome
Observational
200
Amiens, Annecy, Argenteuil, Bayonne, Besançon, Bordeaux, Brive-la-Gaillarde, Caen
2023-09-19
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
La Roche-sur-Yon, Angers, Argenteuil, Belfort, Bourg-en-Bresse, Dieppe, Dijon, Garches
2023-07-22
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Recruiting
Poitiers University Hospital
Not applicable
670
Angers, Argenteuil, Aurillac, Avignon, Belfort, Bordeaux, Bourg-en-Bresse, Brest
2023-02-02
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Active, closed
French Innovative Leukemia Organisation
Observational
1,000
Amiens, Angers, Annecy, Argenteuil, Avignon, Besançon, Béziers, Blois
2022-11-11
Recruiting
Centre Hospitalier Intercommunal Creteil
Not applicable
820
Amiens, Angers, Argenteuil, Belfort, Cholet, Créteil, Dijon, Grenoble
2022-10-01
Recruiting
Hospices Civils de Lyon
Not applicable
204
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand
2022-08-01
Recruiting
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
NCT05198960Polycythemia Vera, Essential Thrombocythemia, Prefibrotic/Early Primary Myelofibrosis, JAK2 V617F
DrugAspirin
University Hospital, Brest
Phase 3
1,308
Angers, Annecy, Argenteuil, Avignon, Bayonne, Béziers, Bordeaux, Brest
2022-07-13
Active, closed
Celgene
Phase 3
939
Argenteuil, La Roche-sur-Yon, Lille, Nancy, Nantes, Paris, Pessac, Rouen
2022-06-23
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Compiègne
2022-05-18
Recruiting
Acute Leukemia French Association
Observational
5,000
Amiens, Argenteuil, Bobigny, Caen, Clamart, Corbeil-Essonnes, Créteil, Dijon
2022-04-14
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Angers, Paris, Poitiers, Amiens, Argenteuil, Béziers, Pierre-Bénite
2022-04-11
Active, closed
Intergroupe Francophone du Myelome
Phase 3
791
Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Blois, Bobigny
2021-12-08
Active, closed
French Innovative Leukemia Organisation
Phase 2
160
Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Clermont-Ferrand, Corbeil-Essonnes
2021-10-18
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Caen, Limoges, Montpellier, Argenteuil, Brest, Grenoble, La Roche-sur-Yon, Le Mans
2021-08-27
Recruiting
Unity Health Toronto
Not applicable
740
Amiens, Angers, Argenteuil, Beauvais, Bordeaux, Brest, Cholet, Créteil
2020-11-23
Active, closed
Intergroupe Francophone du Myelome
Not applicable
395
Abbeville, Amiens, Angers, Annecy, Argenteuil, Arras, Auch, Avignon
2020-02-11
Recruiting
Poitiers University Hospital
Observational
6,000
Angoulême, Argenteuil, Béthune, Chartres, Lille, Montpellier, Nantes, Poitiers
2020-01-09
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Amiens, Angers, Argenteuil, Bayonne, Besançon, Bobigny, Chesnay, Clamart
2019-12-20
Active, closed
Inotrem
Phase 2
355
Angers, Argenteuil, Béthune, Bourg-en-Bresse, Dijon, La Roche-sur-Yon, Le Kremlin-Bicêtre, Le Mans
2019-11-13
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Active, closed
University Hospital, Rouen
Phase 3
92
Amiens, Angers, Argenteuil, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2019-07-11
Active, closed
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
NCT03744390Myelodysplastic Syndromes, Leukemia Acute Myeloid
DrugEnasidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Versailles, Montpellier, Angers, Argenteuil, Bayonne, Bordeaux, Caen, Créteil
2019-04-02
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Amiens, Angers, Argenteuil, Bayonne, Besançon, Bobigny, Chambéry, Chesnay
2019-03-01
Active, closed
BeiGene
Phase 3
590
Argenteuil, Bordeaux, Caen, La Roche-sur-Yon, Le Mans, Limoges, Marseille, Nantes
2017-10-31
Active, closed
Janssen-Cilag International NV
Observational
135
Argenteuil, Besançon, Bordeaux, Brest, Martigues, Paris, Saint-Etienne
2017-10-25
Active, closed
Acerta Pharma BV
Phase 3
635
Argenteuil, Bobigny, Bordeaux, Le Mans, Limoges, Pessac, Périgueux, Rennes
2017-04-05
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Recruiting
UMC Utrecht
Phase 3
20,000
Argenteuil, Aurillac, Beauvais, Belfort, Béthune, Boulogne-Billancourt, Dax, Dieppe
2016-04-11
Recruiting
University Hospital, Angers
Phase 2/3
3,100
Amiens, Angers, Argenteuil, Bayonne, Besançon, Béziers, Bobigny, Bordeaux
2015-01
Rows per page Showing 1–75 of 75
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-france/city/argenteuil

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 75 of those studies with a site in Argenteuil.

How many clinical trials are recruiting in Argenteuil?

34 of the 75 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 15 have not yet opened recruitment, 26 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Argenteuil), 75 studies
PhaseStudiesRecruitingShare
Phase 3271236%
Observational18624%
Not applicable13917.3%
Phase 211414.7%
Phase 1/2314%
Phase 4212.7%
Phase 2/3111.3%

Most active sponsors

Lead sponsors with the most studies (Argenteuil)
Lead sponsorStudiesRecruiting
French Innovative Leukemia Organisation41
Intergroupe Francophone du Myelome41
University Hospital, Angers42
Assistance Publique - Hôpitaux de Paris31
AstraZeneca31
The Lymphoma Academic Research Organisation31
Groupe Francophone des Myelodysplasies21
Janssen Research & Development, LLC21
Nantes University Hospital22
Poitiers University Hospital22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.